Find an MSK Doctor or Cancer Specialist
Dr. Hadar Goldvaser

Hadar Goldvaser, MD

Breast Medical Oncologist

My Role at MSK

Areas of Expertise

Conditions I Treat

  • Breast cancers and conditions
  • Hereditary cancers
  • Young women with breast cancer
View all
Dr. Goldvaser's Office Information
Languages: English & Hebrew
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top
Share

About Me

What I Do at MSK
  • Assistant Attending Physician
Get To Know Me

I am a medical oncologist specializing in breast cancer treatment and research. I see patients at Memorial Sloan Kettering Nassau. My goal is to provide professional and compassionate care to my patients and advance the field of breast cancer treatment through clinical research. I specialize in treating younger women with breast cancer and also people who are carriers of the BRCA gene mutations, which are associated with high risk of breast and ovarian cancer.

People with breast cancer often go through a complex journey to cope with the diagnosis. As their oncologist, I have the privilege to help them navigate through this journey aiming to provide the best possible care to each person.

Read more

Breast cancer treatment has evolved over the last few decades and patients now have many options. I focus on tailoring treatment to each person’s specific cancer diagnosis, coexisting health conditions, and their personal goals and life situations. I make sure my patients understand the potential benefits and risks of each treatment so we can work together to make decisions and help them receive the best possible cancer care. Working together with a diverse team of experts, including surgeons, radiologists, radiation oncologists, pathologists, and supportive care, I aim to provide comprehensive treatment.

I am also actively involved in researching breast cancer. My research focuses on better understanding common clinical dilemmas in the treatment of breast cancer. I have led several high-impact studies that aim to better quantify the risks of common breast cancer therapies and to define treatment effectiveness in different settings. Ultimately, these studies highlight the risk-benefit balance of different therapies for breast cancer and support more informed treatment choices. My research directly improves the quality of the clinical care I provide.

While newly developed therapies are available for BRCA carriers, they may also need to manage additional aspects such as coping with cancer at a younger age, decisions on risk-reducing surgery, fertility preservation, and long-term monitoring. I address each person’s unique needs to provide the best and most comprehensive care.

A breast cancer diagnosis can feel overwhelming, and the treatment may seem complex and difficult. I want to assure my patients that they are not alone. I am here for them at every step, to address their questions and concerns and sometimes just to listen and support. My dedication to the well-being of my patients extends beyond their diagnosis and treatment, and I am committed to doing everything I can for them.

My Role at MSK

A breast medical oncologist is a cancer doctor who specializes in breast cancer.

Areas of Expertise

Conditions I Treat

  • Breast cancers and conditions
  • Hereditary cancers
  • Young women with breast cancer
Education & Honors

Education

  • MD, The Ruth and Bruce Rappaport Faculty of Medicine, Israel

Residencies

  • Medical Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Israel

Awards and Honors

  • Merit award, European Society of Medical Oncology (ESMO) Annual Congress (2018)
  • First place in the Mimi and Charles Hollenberg Research Competition of the Department of Medicine of Mount Sinai Hospital and the University Health Network (2018)

Fellowships

  • Medical Oncology, Breast Cancer, Princess Margaret Cancer Centre, Canada

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (MTA and NYC retirees only)

In Network Coverage Type
PPO

Anthem BCBS and other BCBS licensee plans

In Network Coverage Type
PPO, POS, EPO, HMO

See updates

Anthem BCBS Health Plus

In Network Coverage Type
HMO

See updates

Anthem Blue Cross Medicare Advantage

In Network Coverage Type
PPO, HMO, DSN

See updates

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

See updates

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

See updates

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage (Medicare Choice PPO Network and VIP Prime Network Only)

In Network Coverage Type
PPO, HMO

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

See updates

Fidelis

In Network Coverage Type
HMO, EPO

Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

See updates

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

See updates

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

See updates

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

See updates

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 800-525-2225— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.

Contact and Location

Dr. Goldvaser sees patients at one location.

Location
Uniondale, NY
Memorial Sloan Kettering Nassau
1101 Hempstead Turnpike Uniondale NY 11553
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Breast Medicine Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

  1. Goldvaser H, Barnes TA, Šeruga B, Cescon DW, Ocaña A, Ribnikar D, Amir E. Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: a systematic review and meta-analysis. JNCI: Journal of the National Cancer Institute. 2018 Jan;110(1):31-9.
  2. Goldvaser H, Korzets Y, Shepshelovich D, Yerushalmi R, Sarfaty M, Ribnikar D, Thavendiranathan P, Amir E. Deescalating adjuvant trastuzumab in HER2-positive early-stage breast cancer: a systemic review and meta-analysis. JNCI cancer spectrum. 2019 Jun;3(2):pkz033.
  3. Shepshelovich D, Tibau A, Goldvaser H, Molto C, Ocana A, Seruga B, Amir E. Postmarketing modifications of drug labels for cancer drugs approved by the US Food and Drug Administration between 2006 and 2016 with and without supporting randomized controlled trials. Journal of Clinical Oncology. 2018 Jun 20;36(18):1798-804.
  4. Korzets Y, Fyles A, Shepshelovich D, Amir E, Goldvaser H. Toxicity and clinical outcomes of partial breast irradiation compared to whole breast irradiation for early-stage breast cancer: a systematic review and meta-analysis. Breast cancer research and treatment. 2019 Jun 30;175:531-45.
  5. Mutai R, Barkan T, Moore A, Sarfaty M, Shochat T, Yerushalmi R, Stemmer SM, Goldvaser H. Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer. The Breast. 2021 Dec 1;60:62-9.
Publications on PubMed

Visit PubMed for a full listing of Dr. Goldvaser’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed